Trial Profile
A Retrospective study to evaluate the efficacy of intravitreal Bevacizumab combined with laser photocoagulation in patients with Coats' disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinal telangiectasis
- Focus Therapeutic Use
- 18 Apr 2017 New trial record